Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haemate HS for severe intraoperative bleeding during aortic valve replacement for aortic stenosis
2006-005296-18Phase 2Terminated
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of factor viii + von Willebrand factor in Bleeding and coagulation defects (2 arms), sponsored by Heinrich Heine University Düsseldorf. Primary endpoints: Hemostasis during severe intraoperative bleeding complications and Safety of Haemate HS. Started Apr 2007; status: terminated.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
Bleedingcoagulation defects
Beyond the preview
Go deeper on 2006-005296-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005296-18.